“In Silico Characterization of a Novel Bioactive Compound Derived from Psidium Guajava 4-[5-(Pyridin-4-Yl)-1,2,4-Oxadiazol-3-Yl]-1,2,5-Oxadiazol-3-Amine: A Potential Inhibitor for Targeting Signaling Proteins Involved in Diabetes Development”. International Journal of Pharmaceutical Sciences and Drug Research 16, no. 2 (March 30, 2024): 180–190. Accessed May 18, 2024. https://www.ijpsdr.com/index.php/journal/article/view/8584.